Per-Se appoints new CEO following Ritchie departure

Article

Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the

Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the positions of executive vice president and COO for the firm. Per-Se provides business management services to physicians and claims to support 35,000 physicians and 2000 healthcare organizations.


© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.